Brad Briggs: Articles
March 16, 2010
Own a Piece of Brazil's Future

Investors who want to capture the real potential of emerging powerhouses like Brazil won't look to the traditional exchange-traded funds on the market. They'll look here instead...

 
March 11, 2010
Inside the Numbers: Profiting from the 'Short Squeeze'

When investors 'short' a stock, they're betting its price will go down, much to the chagrin of 'longs,' who want it to go up. When a short seller is wrong, he has to cover his position before he loses his shirt. This week's Inside the Numbers shows investors how to help the shorts lose their shirts -- and get rich in the process.

 
March 5, 2010
Inside the Numbers: Using Wall Street Experts to Your Advantage

Stocks with a high number of 'Buy' ratings are a dime a dozen. But these stocks are the absolute darlings of Wall Street. A quick run of the numbers shows some interesting (and potentially underpriced) candidates.

 
February 19, 2010
Inside the Numbers: The Best DRIPs in America

Dividends play a vital role in the market. Combined with a good dividend reinvestment plan, they can create substantial wealth for investors over time. Find out the best DRIPs in the market today.

 
February 16, 2010
Inside the Numbers: Recent IPO Winners

Who hasn't dreamed of hitting the jackpot with an initial public offering (IPO)? The recent economic downturn has led to a relative dearth of opportunities in the IPO market, but you might be surprised by the strength of some of the names on the list.

 
January 29, 2010
The Sugar Crisis Spells Opportunity for Investors

Sugar prices have reached a 29-year high and could be headed higher. Read more to learn the best way to profit.

 
January 19, 2010
Lessons from the Greatest Silver Bust in History

Between 1973 and 1980, two sons of a legendary Texas oil baron made the bet of a lifetime. It would eventually go down as one of the most notorious busts in the history of Wall Street.

 
January 15, 2010
Don't Miss the Best Pharma Value on the Market

One of the market's most well-known drug giants is trading at single digit valuations -- a value that won't last long. Plus, the company has paid dividends for more than 120 years and yields 5.5%.

 
January 8, 2010
Three Underrated ETF Hotspots

These three countries should be on investors' radar screens for 2010. They may not be the first places that come to mind, but they have a shot at being the year's top performers.

 
January 5, 2010
The World's Secret Printing Press

If you thought most governments printed money themselves, you're wrong -- they're turning in droves to have one company do the job for them. Learn about this secret company that will profit as governments shift their printing presses into overdrive.